Company intelligence / Profile preview

Birgi Mefar Group

Istanbul, Istanbul, Turkeymefar.com ↗

Ownership: Private
Employees: ~413
Development stage: Commercial

Overview

Birgi Mefar Group is a leading Turkish-based CDMO specializing in sterile pharmaceutical development and contract manufacturing of small and medium volume parenteral solutions. It offers comprehensive services from solution preparation to aseptic filling, packaging, cold chain management, analytical testing, stability studies, technology transfer, and regulatory support. The group holds more than 10 GMP certifications from global authorities including the Turkish Health Authority and EMA. It was acquired by Abu Dhabi Developmental Holding Company PJSC in June 2022.

Modalities: Small moleculeBiologicProteinPeptideVaccine
Industry: Contract Manufacturing Organization

Partnerships

Serves local and Fortune 500 pharmaceutical companies as clients

Beyond the preview

Go deeper on Birgi Mefar Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Birgi Mefar Group.

Explore the full profile